Derek Gauntlett

Director, Process Chemistry, Nucleic Acid Development & Manufacturing at Codexis

Speaker

Mr. Gauntlett joined Codexis in 2023 to oversee process development for the company’s ECO Synthesis™ platform, bringing over 13 years of research and development experience in biotech with a focus in therapeutic modalities, such as enzyme and nucleic acids, from preclinical to commercialization. Prior to joining Codexis, Mr. Gauntlett was pivotal in establishing LGC's rapidly expanding Axolabs division overseeing Chemistry, Manufacturing and Controls group (CMC) of RNA-based therapeutics development. Prior to LGC Axolabs, Mr. Gauntlett worked at BioMarin Pharmaceuticals where he focused on process sciences research and scaled an early-phase drug candidates to commercial production.

Mr. Gauntlett received his B.S. from California State Polytechnic University, Humboldt, and an MBA from Sonoma State University.